{
  "retracted": false,
  "timestamp": 1564099200000,
  "updates": [
    {
      "timestamp": 1566891645611,
      "identifier": {
        "doi": "10.1038/s41416-019-0528-0"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1038/s41416-018-0343-z"
  },
  "journal": "British Journal of Cancer",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction: A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer"
}
